Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Innovation Pharmaceuticals IPIX
(Total Views: 582)
Posted On: 06/19/2022 3:09:40 PM
Post# of 72445
Posted By: farrell
Re: Drano #71932
Squalus, IPIX's partner, is planning to have the new system evaluated by the FDA 510k path.

IMO the system is likely to use a laser already approved for human treatment, since the PR did not mention a new laser.

In addition laser treatments have been performed for a number of years for all the indications indicated in the PR, epilepsy and tumors of the brain, lung,prostate,breast and liver.

The Squalus laser system may be viewed by the FDA primarily as an imaging and software change to better direct the laser treatment and as such may require a much shorter path to the 510k approval.

Investors will have to wait until these points are clarified by the FDA and Squalus.

https://www.fda.gov/media/99785/download

The quote below does not apply to the Squalus system since it is applying for the 510k designation. It is placed here to show software changes are held to a different level of scrutiny.

"Many software functions are not medical devices (meaning such software functions do not meet the definition of a device under section 201(h) of the Federal Food, Drug, and Cosmetic Act (FD&C Act)), and FDA does not regulate them as devices."

https://www.fda.gov/media/80958/download

Good luck, Farrell













(4)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site